US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist
  • 0.6111
  • -0.0014-0.23%
Close May 31 16:00 ET
  • 0.6236
  • +0.0125+2.05%
Post 16:57 ET
10.68MMarket Cap-1175P/E (TTM)

Monopar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-24.69%8.79M
-44.62%7.27M
-44.62%7.27M
-40.66%8.49M
-38.10%10.19M
-34.47%11.68M
-35.38%13.12M
-35.38%13.12M
-35.92%14.32M
-32.23%16.46M
-Cash and cash equivalents
36.36%7.81M
-11.24%7.27M
-11.24%7.27M
-61.48%5.52M
-56.18%7.21M
-67.87%5.73M
-59.68%8.19M
-59.68%8.19M
-35.92%14.32M
-32.23%16.46M
-Short-term investments
-83.43%985.73K
--0
--0
--2.98M
--2.98M
--5.95M
--4.93M
--4.93M
----
----
Other current assets
11.39%118.99K
44.48%66.43K
44.48%66.43K
31.41%73.19K
-41.92%109.87K
-44.83%106.82K
-78.88%45.98K
-78.88%45.98K
-47.85%55.7K
97.96%189.18K
Total current assets
-24.36%8.91M
-44.31%7.33M
-44.31%7.33M
-40.38%8.57M
-38.14%10.3M
-34.58%11.78M
-35.84%13.17M
-35.84%13.17M
-35.98%14.37M
-31.72%16.65M
Non current assets
Net PPE
--0
-79.35%12.65K
-79.35%12.65K
-65.58%25.09K
-55.75%37.33K
-8.04%49.38K
--61.23K
--61.23K
--72.89K
--84.36K
-Gross PPE
--0
-79.35%12.65K
-79.35%12.65K
-65.58%25.09K
-55.75%37.33K
-8.04%49.38K
--61.23K
--61.23K
--72.89K
--84.36K
Total non current assets
--0
-79.35%12.65K
-79.35%12.65K
-65.58%25.09K
-55.75%37.33K
-8.04%49.38K
--61.23K
--61.23K
5.85%72.89K
22.52%84.36K
Total assets
-24.68%8.91M
-44.47%7.35M
-44.47%7.35M
-40.51%8.59M
-38.23%10.34M
-34.51%11.83M
-35.55%13.23M
-35.55%13.23M
-35.85%14.45M
-31.57%16.74M
Liabilities
Current liabilities
Current liabilities
-50.30%1.44M
-43.83%1.76M
-43.83%1.76M
3.53%1.98M
14.40%2.5M
168.85%2.89M
97.96%3.13M
97.96%3.13M
54.39%1.91M
98.16%2.19M
Non current liabilities
Long term debt and capital lease obligation
----
--0
--0
--0
--0
--0
--8.41K
--8.41K
--20.85K
--33.09K
-Long term capital lease obligation
----
--0
--0
--0
--0
--0
--8.41K
--8.41K
--20.85K
--33.09K
Total non current liabilities
--0
--0
--0
--0
--0
--0
--8.41K
--8.41K
--20.85K
--33.09K
Total liabilities
-50.30%1.44M
-43.98%1.76M
-43.98%1.76M
2.41%1.98M
12.69%2.5M
162.65%2.89M
98.50%3.14M
98.50%3.14M
56.07%1.94M
101.16%2.22M
Shareholders'equity
Share capital
32.23%17.48K
15.12%14.91K
15.12%14.91K
10.44%14.2K
9.42%13.9K
4.76%13.22K
2.77%12.95K
2.77%12.95K
2.10%12.86K
0.94%12.7K
-common stock
32.23%17.48K
15.12%14.91K
15.12%14.91K
10.44%14.2K
9.42%13.9K
4.76%13.22K
2.77%12.95K
2.77%12.95K
2.10%12.86K
0.94%12.7K
Retained earnings
-14.03%-61.85M
-16.22%-60.21M
-16.22%-60.21M
-19.39%-58.39M
-21.35%-56.44M
-23.99%-54.24M
-25.47%-51.8M
-25.47%-51.8M
-26.68%-48.91M
-28.66%-46.51M
Paid-in capital
9.76%69.3M
6.34%65.79M
6.34%65.79M
5.91%64.99M
5.34%64.25M
4.01%63.14M
2.74%61.87M
2.74%61.87M
2.48%61.36M
2.52%60.99M
Gains losses not affecting retained earnings
-86.69%4.23K
-258.04%-14.13K
-258.04%-14.13K
-90.81%3.95K
-58.65%7.22K
949.01%31.79K
382.97%8.94K
382.97%8.94K
935.15%42.99K
438.75%17.47K
Total stockholders'equity
-16.41%7.48M
-44.62%5.59M
-44.62%5.59M
-47.15%6.61M
-46.02%7.84M
-47.28%8.94M
-46.73%10.09M
-46.73%10.09M
-41.21%12.51M
-37.84%14.52M
Total equity
-16.41%7.48M
-44.62%5.59M
-44.62%5.59M
-47.15%6.61M
-46.02%7.84M
-47.28%8.94M
-46.73%10.09M
-46.73%10.09M
-41.21%12.51M
-37.84%14.52M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -24.69%8.79M-44.62%7.27M-44.62%7.27M-40.66%8.49M-38.10%10.19M-34.47%11.68M-35.38%13.12M-35.38%13.12M-35.92%14.32M-32.23%16.46M
-Cash and cash equivalents 36.36%7.81M-11.24%7.27M-11.24%7.27M-61.48%5.52M-56.18%7.21M-67.87%5.73M-59.68%8.19M-59.68%8.19M-35.92%14.32M-32.23%16.46M
-Short-term investments -83.43%985.73K--0--0--2.98M--2.98M--5.95M--4.93M--4.93M--------
Other current assets 11.39%118.99K44.48%66.43K44.48%66.43K31.41%73.19K-41.92%109.87K-44.83%106.82K-78.88%45.98K-78.88%45.98K-47.85%55.7K97.96%189.18K
Total current assets -24.36%8.91M-44.31%7.33M-44.31%7.33M-40.38%8.57M-38.14%10.3M-34.58%11.78M-35.84%13.17M-35.84%13.17M-35.98%14.37M-31.72%16.65M
Non current assets
Net PPE --0-79.35%12.65K-79.35%12.65K-65.58%25.09K-55.75%37.33K-8.04%49.38K--61.23K--61.23K--72.89K--84.36K
-Gross PPE --0-79.35%12.65K-79.35%12.65K-65.58%25.09K-55.75%37.33K-8.04%49.38K--61.23K--61.23K--72.89K--84.36K
Total non current assets --0-79.35%12.65K-79.35%12.65K-65.58%25.09K-55.75%37.33K-8.04%49.38K--61.23K--61.23K5.85%72.89K22.52%84.36K
Total assets -24.68%8.91M-44.47%7.35M-44.47%7.35M-40.51%8.59M-38.23%10.34M-34.51%11.83M-35.55%13.23M-35.55%13.23M-35.85%14.45M-31.57%16.74M
Liabilities
Current liabilities
Current liabilities -50.30%1.44M-43.83%1.76M-43.83%1.76M3.53%1.98M14.40%2.5M168.85%2.89M97.96%3.13M97.96%3.13M54.39%1.91M98.16%2.19M
Non current liabilities
Long term debt and capital lease obligation ------0--0--0--0--0--8.41K--8.41K--20.85K--33.09K
-Long term capital lease obligation ------0--0--0--0--0--8.41K--8.41K--20.85K--33.09K
Total non current liabilities --0--0--0--0--0--0--8.41K--8.41K--20.85K--33.09K
Total liabilities -50.30%1.44M-43.98%1.76M-43.98%1.76M2.41%1.98M12.69%2.5M162.65%2.89M98.50%3.14M98.50%3.14M56.07%1.94M101.16%2.22M
Shareholders'equity
Share capital 32.23%17.48K15.12%14.91K15.12%14.91K10.44%14.2K9.42%13.9K4.76%13.22K2.77%12.95K2.77%12.95K2.10%12.86K0.94%12.7K
-common stock 32.23%17.48K15.12%14.91K15.12%14.91K10.44%14.2K9.42%13.9K4.76%13.22K2.77%12.95K2.77%12.95K2.10%12.86K0.94%12.7K
Retained earnings -14.03%-61.85M-16.22%-60.21M-16.22%-60.21M-19.39%-58.39M-21.35%-56.44M-23.99%-54.24M-25.47%-51.8M-25.47%-51.8M-26.68%-48.91M-28.66%-46.51M
Paid-in capital 9.76%69.3M6.34%65.79M6.34%65.79M5.91%64.99M5.34%64.25M4.01%63.14M2.74%61.87M2.74%61.87M2.48%61.36M2.52%60.99M
Gains losses not affecting retained earnings -86.69%4.23K-258.04%-14.13K-258.04%-14.13K-90.81%3.95K-58.65%7.22K949.01%31.79K382.97%8.94K382.97%8.94K935.15%42.99K438.75%17.47K
Total stockholders'equity -16.41%7.48M-44.62%5.59M-44.62%5.59M-47.15%6.61M-46.02%7.84M-47.28%8.94M-46.73%10.09M-46.73%10.09M-41.21%12.51M-37.84%14.52M
Total equity -16.41%7.48M-44.62%5.59M-44.62%5.59M-47.15%6.61M-46.02%7.84M-47.28%8.94M-46.73%10.09M-46.73%10.09M-41.21%12.51M-37.84%14.52M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg